Journal article
Rapid burst of H2O2 by plant growth regulators increases intracellular Ca2+ amounts and modulates CD4+ T cell activation
- Abstract:
- The identification of small molecules that affect T cell activation is an important area of research. Three molecules that regulate plant growth and differentiation, but not their structurally similar analogs, were identified to enhance primary mouse CD4(+) T cell activation in conjunction with soluble anti-CD3 stimulation: Indoleacetic acid (natural plant auxin), 1-Napthaleneacetic acid (synthetic plant auxin) and 2,4-Dichlorophenoxyacetic acid (synthetic plant auxin and herbicide). These effects are distinct in comparison to Curcumin, the well known phenolic immunomodulator, which lowers T cell activation. An investigation into the mechanisms of action of the three plant growth regulators revealed a rapid induction of reactive oxygen species (ROS), mainly comprising H(2)O(2). In addition, these three molecules synergize with soluble anti-CD3 signaling to enhance intracellular Ca(2+) concentrations [Ca(2+)](i), leading to greater T cell activation, e.g. induction of CD25 and IL-2. Enhanced production of TNFα and IFNγ by CD4(+) T cells is also observed upon plant growth regulator treatment with soluble anti-CD3. Interestingly, maximal IL-2 production and CD4(+) T cell cycle progression are observed upon activation with soluble anti-CD3 and phorbol 12-myristate 13-acetate (PMA), a phorbol ester. Additionally, stimulation with PMA and Ionomcyin (a Ca(2+) ionophore), which activates T cells by circumventing the TCR, and plant growth regulators also demonstrated the role of the strength of signal (SOS): T cell cycle progression is enhanced with gentle activation conditions but decreased with strong activation conditions. This study demonstrates the direct effects of three plant growth regulators on CD4(+) T cell activation and cycling.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 230.5KB, Terms of use)
-
(Preview, Figures/images, pdf, 473.8KB, Terms of use)
-
(Preview, Supplementary materials, pdf, 239.4KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.intimp.2010.08.005
Authors
- Publisher:
- Elsevier
- Journal:
- International Immunopharmacology More from this journal
- Volume:
- 10
- Issue:
- 11
- Pages:
- 1397-1405
- Place of publication:
- Netherlands
- Publication date:
- 2010-08-20
- Acceptance date:
- 2010-08-05
- DOI:
- EISSN:
-
1878-1705
- ISSN:
-
1567-5769
- Pmid:
-
20728597
- Language:
-
English
- Keywords:
- Pubs id:
-
370409
- Local pid:
-
pubs:370409
- Deposit date:
-
2024-08-14
- ARK identifier:
Terms of use
- Copyright holder:
- Elsevier
- Copyright date:
- 2010
- Rights statement:
- © 2010 Elsevier B.V. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final version is available from Elsevier at: 10.1016/j.intimp.2010.08.005
If you are the owner of this record, you can report an update to it here: Report update to this record